⌘K

Login Start Free

Home/Filings/4/0001104659-20-057472

4//SEC Filing

Mann Brenda 4

Accession 0001104659-20-057472

CIK 0001372514other

View on SEC.gov Company Profile

Filed

May 5, 8:00 PM ET

Accepted

May 6, 4:31 PM ET

Size

4.7 KB

Accession

0001104659-20-057472

Insider Transaction Report

Form 4

Period: 2020-05-05

EYEGATE PHARMACEUTICALS INCEYEG

VP of Research & Development

Transactions

Tax Payment
Common Stock
2020-05-05$5.10/sh−113$576→ 18,033 total

Footnotes (1)

[F1]Sale of shares to cover taxes due on restricted stock that vested on 05/01/2020.

Documents

1 file

4
tm2018856d3_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

EYEGATE PHARMACEUTICALS INC

CIK 0001372514

Entity typeother

Related Parties

1

filerCIK 0001668858

Filing Metadata

Form type: 4
Filed: May 5, 8:00 PM ET
Accepted: May 6, 4:31 PM ET
Size: 4.7 KB

View on SEC.gov